Freeze-drying composition including cell culture supernatant
A trehalose and hyaluronate-based composition stabilizes the freeze-drying of cell culture supernatant, addressing appearance issues and ensuring uniformity and stability in the final product.
Patent Information
- Application Number
- JP2023078402
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-11
- Publication Date
- 2024-11-21
AI Technical Summary
The freeze-drying of cell culture supernatant results in non-uniform product appearance due to air bubbles and spongy structures, leading to poor stability and variability in the final product form.
A composition containing trehalose and hyaluronate, specifically sodium hyaluronate, is added to the cell culture supernatant to prevent bubble formation and achieve a stable, uniform product form during freeze-drying.
The composition effectively prevents air bubbles and ensures a consistent, stable product form without variations, enhancing the freeze-drying process and product quality.
Smart Images

Figure 2024162664000001 
Figure 2024162664000002 
Figure 2024162664000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a composition for freeze-drying comprising a cell culture supernatant. The present invention also relates to a freeze-dried product obtained by freeze-drying the composition for freeze-drying comprising a cell culture supernatant. [Background technology]
[0002] Mesenchymal stem cells are somatic stem cells present in bone marrow, synovium, fat, and umbilical cord, and have been reported to have the ability to differentiate into cartilage, bone, fat, and nerve cells (Non-Patent Document 1). Because they can be isolated from adult tissues, they are used in regenerative treatment of damaged areas of the meniscus and cartilage (Non-Patent Document 2). In addition, mesenchymal stem cells also have anti-inflammatory and immunoregulatory effects, and are therefore known to have been widely used for various diseases, such as liver disease, graft-versus-host disease, and autoimmune diseases.
[0003] In this context, it has become clear that the function of these mesenchymal stem cells transplanted into the body in cell transplantation therapy is greatly influenced by physiologically active substances such as various cytokines secreted by mesenchymal cells.
[0004] When mesenchymal stem cells are cultured in vitro, these physiologically active substances are released into the culture medium. There have been reports of successful cases in which the culture medium used for culturing mesenchymal stem cells was collected and used to regenerate tissues, since the culture medium contains a large amount of substances released from the cells (Non-Patent Documents 3, 4, and 5).
[0005] Thus, the culture supernatant produced during the culture process of cells such as mesenchymal stem cells is rich in signaling substances that play an important role in cell activity, such as growth factors and immune regulatory factors (cytokines) secreted from stem cells, including exosomes, and is thought to be useful for restoring the functions of damaged tissues and cells in the body. Exosomes, growth factors, cytokines, etc., which are abundant in the culture supernatant, act on surrounding stem cells and are expected to have a functional recovery effect such as tissue regeneration and improved immunity by collecting cells at sites where function has been reduced due to aging or damage. Therefore, it is necessary to prepare a culture supernatant of cells.
[0006] Trehalose is known to be used as an additive, for example, Patent Document 1 describes the inclusion of trehalose as a stabilizer in a therapeutic peptibody composition, and Patent Document 2 describes the inclusion of trehalose in a lyophilized composition containing non-autologous plasma or serum. Hyaluronic acid is also known to be used as an additive, for example, Patent Document 1 describes the inclusion of hyaluronic acid as a stabilizer in a therapeutic peptibody composition, and Patent Document 2 describes the inclusion of hyaluronic acid as an additive in a lyophilized composition containing non-autologous plasma or serum. [Prior art documents] [Patent documents]
[0007] [Patent Document 1] JP 2022-166219 A [Patent Document 2] JP 2022-191232 A [Non-patent literature]
[0008] [Non-Patent Document 1] Colter, D. C., Sekiya, I. & Prockop, D. J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci. 2001;98:7841-7845. [Non-Patent Document 2] Sekiya I., Muneta T., Horie M. & Koga H. Arthroscopic Transplantation of Synovial Stem Cells Improves Clinical Outcomes in Knees With Cartilage Defects. Clin Orthop Relat Res. 2015;473:2316-26. [Non-Patent Document 3] Osugi M., Katagiri, W., Yoshimi, R., Inukai, T., Hibi, H., Ueda M. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Engineering Part A.2012;18:1479-1489 [Non-Patent Document 4] Shohara, R., Yamamoto, A., Takikawa, S., Iwase, A., Hibi, H., Kikkawa, F., Ueda, M. Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms. Cytotherapy,2012;14(10):1171-1181 [Non-Patent Document 5] Kawai, T., Katagiri, W., Osugi, M., Sugimura, Y., Hibi, H., Ueda, M. Secretomes from bone marrow-derived mesenchymal stromal cells enhance periodontal tissue regeneration. Cytotherapy,2015;17(4):369-381 Summary of the Invention [Problem to be solved by the invention]
[0009] When the cell culture supernatant was freeze-dried, only powder residue remained, and the appearance of the containers differed, resulting in no uniformity in appearance. Therefore, in order to add an excipient to the cell culture supernatant, trehalose was added to the cell culture supernatant and freeze-dried, but air bubbles were observed after molding, and the problem of the product's appearance was not solved. Also, when sodium hyaluronate was added to the cell culture supernatant and freeze-dried, a sponge-like structure was formed in some cases, and the stability during molding was poor, and similarly, the problem of the product's appearance was not solved. Therefore, the object of the present invention is to provide a composition for freeze-drying containing a cell culture supernatant, which does not generate air bubbles even when freeze-dried, and achieves an excellent product shape. [Means for solving the problem]
[0010] The present inventors have conducted extensive research and found that a composition containing cell culture supernatant, trehalose, and hyaluronate does not generate bubbles even when freeze-dried, and achieves an excellent product shape, making it an excellent composition for freeze-drying. Although any composition in which either trehalose or hyaluronate is added to cell culture supernatant generates bubbles when freeze-dried, it is completely unexpected that a composition containing both of these does not generate bubbles even when freeze-dried and achieves an excellent product shape. In addition, when mannitol, another additive, is added to cell culture supernatant and freeze-dried, no improvement in appearance is observed, and on the contrary, further expansion is observed, and the appearance of the product is rather deteriorated. In view of this, the findings of the present inventors are extremely unexpected.
[0011] That is, the present invention provides the following. [Section 1] A composition for freeze-drying comprising a cell culture supernatant, trehalose, and a hyaluronate. [Section 2] Item 2. The composition for freeze-drying according to Item 1, wherein the cells are stem cells. [Section 3] Item 3. The composition for freeze-drying according to Item 2, wherein the stem cells are umbilical cord tissue-derived stem cells. [Section 4] Item 2. The composition for freeze-drying according to Item 1, wherein the cell culture supernatant is a supernatant of a culture medium in which cells are cultured, and the culture medium is a medium containing glucose. [Section 5] Item 5. The composition for freeze-drying according to Item 4, wherein the glucose content in the glucose-containing medium is 0.5 to 20 g / L relative to the medium when the cell culture in the glucose-containing medium is terminated. [Section 6] Item 5. The composition for freeze-drying according to Item 4, wherein the medium in the medium containing glucose is a basal medium. [Section 7] Item 5. The composition for freeze-drying according to item 4, wherein the cells are washed before being cultured in a medium containing glucose. [Section 8] Item 2. The composition for freeze-drying according to Item 1, wherein the cells are cultured in a medium containing a recombinant protein. [Section 9] Item 2. The composition for freeze-drying according to Item 1, wherein the cells are cultured in a serum-free medium. [Section 10] Item 2. The composition for freeze-drying according to Item 1, wherein the cells are cultured in a medium for adipose-derived stem cells. [Section 11] Item 2. The composition for freeze-drying according to Item 1, wherein the cells are cultured in a medium for mesenchymal stem cells. [Section 12] Item 2. The composition for freeze-drying according to Item 1, wherein the cell culture supernatant is a supernatant of a culture solution in which cells are cultured, and the cell culture supernatant is obtained by filtering the culture solution through a filter. [Section 13] Item 13. A composition for freeze-drying according to Item 12, wherein the filter has a filtration grain size of 0.1 μm to 1.0 μm. [Section 14] Item 2. The composition for freeze-drying according to Item 1, wherein the cell culture supernatant is a concentrated solution of exosomes. [Section 15] Item 2. The composition for freeze-drying according to Item 1, wherein the content of trehalose in the composition for freeze-drying is 1 to 10% by mass, and the content of hyaluronate in the composition for freeze-drying is 0.01 to 0.5% by mass. [Section 16] Item 16. The composition for freeze-drying according to item 15, wherein the content of trehalose in the composition for freeze-drying is 5 to 10% by mass, and the content of hyaluronate in the composition for freeze-drying is 0.1 to 0.3% by mass. [Section 17] Item 2. The composition for freeze-drying according to Item 1, wherein the hyaluronate is sodium hyaluronate. [Section 18] Item 18. A lyophilized product obtained by freeze-drying the composition for freeze-drying according to any one of Items 1 to 17. [Section 19] Item 19. A pharmaceutical composition, a cosmetic composition, or a food product comprising the lyophilized product according to item 18. Effect of the Invention
[0012] The composition for freeze-drying of the present invention does not generate air bubbles even when freeze-dried, and realizes an excellent product shape. [Brief description of the drawings]
[0013] [Figure 1] FIG. 1 is a photograph showing the appearance of the freeze-dried product obtained by freeze-drying only the culture supernatant obtained in Test Example 1. [Diagram 2] FIG. 2 is a photograph showing the appearance of a freeze-dried product obtained by freeze-drying a composition for freeze-drying containing 0.1% by mass of sodium hyaluronate, which was obtained by adding sodium hyaluronate to the culture supernatant obtained in Test Example 1. [Diagram 3] FIG. 3 is a photograph showing the appearance of a freeze-dried product obtained by freeze-drying a composition for freeze-drying containing 0.2% by mass of sodium hyaluronate, which was obtained by adding sodium hyaluronate to the culture supernatant obtained in Test Example 1. [Figure 4] Fig. 4 is a photograph showing the appearance of a freeze-dried product obtained by freeze-drying a composition for freeze-drying containing 5% by mass of trehalose and 0 to 30 mg / ml of mannitol, which was obtained by adding trehalose and, as necessary, mannitol to the culture supernatant obtained in Test Example 1. Fig. 4 shows the results when the trehalose content was 5% by mass and the mannitol content was 0 mg / ml, 10 mg / ml, 20 mg / ml, and 30 mg / ml, from the left. [Diagram 5] Fig. 5 is a photograph showing the appearance of a freeze-dried product obtained by freeze-drying a composition for freeze-drying containing 10% by mass of trehalose and 0 to 30 mg / ml of mannitol, which was obtained by adding trehalose and, as necessary, mannitol to the culture supernatant obtained in Test Example 1. Fig. 5 shows the results when the trehalose content was 10% by mass and the mannitol content was 0 mg / ml, 10 mg / ml, 20 mg / ml, and 30 mg / ml, from the left. [Figure 6]FIG. 6 is a photograph showing the appearance of a freeze-dried product obtained by freeze-drying a composition for freeze-drying containing 5% by mass of trehalose and 0.2% by mass of sodium hyaluronate, which was obtained by adding trehalose and sodium hyaluronate to the culture supernatant obtained in Test Example 1. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0014] The present invention provides a composition for freeze-drying, comprising a cell culture supernatant, trehalose, and a hyaluronate.
[0015] Trehalose is a disaccharide formed by the 1,1-glycosidic bond of glucose. 12 H 22 O 11 Trehalose is represented by the chemical formula: In addition to anhydrous trehalose, dihydrate trehalose is also known. The CAS registration number for anhydrous trehalose is 99-20-7, and the CAS registration number for dihydrate trehalose is 6138-23-4.
[0016] The content of trehalose in the composition for freeze-drying of the present invention, calculated as the content of trehalose dihydrate, is preferably 1 to 10 mass% relative to the composition for freeze-drying, more preferably 3 to 10 mass% relative to the composition for freeze-drying, and even more preferably 5 to 10 mass% relative to the composition for freeze-drying.
[0017] Hyaluronate is a salt of hyaluronic acid. Examples of the salt of hyaluronic acid include sodium hyaluronate, potassium hyaluronate, calcium hyaluronate, zinc hyaluronate, ascorbyl hyaluronate, ascorbyl propyl hyaluronate, propylene glycol hyaluronate, polyethylene glycol ester of hyaluronate, hyaluronic acid crosspolymer, dimethylsilanol hyaluronate, hydroxypropyltrimonium hyaluronate, sodium retinoyl hyaluronate, etc.
[0018] Hyaluronic acid is a type of linear glycosaminoglycan (mucopolysaccharide), in which N-acetylglucosamine and D-glucuronic acid (GlcNAcβ1-4GlcAβ1-3) are linked in a linear chain, and has a structure in which disaccharide units are linked. The molecular weight of hyaluronic acid in the hyaluronate salt contained in the composition for freeze-drying of the present invention is, for example, 4 million to 2 million, preferably 10,000 to 1 million, more preferably 30,000 to 800,000, and even more preferably 50,000 to 700,000. Examples of hyaluronic acid include hyaluronic acid isolated from animal tissues such as chicken comb, and hyaluronic acid produced by microorganisms such as lactic acid bacteria.
[0019] The content of the hyaluronate in the composition for freeze-drying of the present invention is preferably 0.01 to 0.5% by mass, more preferably 0.1 to 0.5% by mass, and even more preferably 0.1 to 0.3% by mass, based on the composition for freeze-drying.
[0020] The cells in the cell culture supernatant are preferably stem cells. The stem cells are preferably umbilical cord tissue-derived stem cells. It is known that umbilical cord tissue-derived stem cells include mesenchymal stem cells, hematopoietic stem cells, and neural crest stem cells. Therefore, the cells in the cell culture supernatant are preferably mesenchymal stem cells, hematopoietic stem cells, or neural crest stem cells, and more preferably mesenchymal stem cells. The cells in the cell culture supernatant are preferably animal cells. Examples of animals include vertebrates and invertebrates. Examples of vertebrates include fish, amphibians, reptiles, birds, and mammals. Examples of mammals include mice and humans. Examples of invertebrates include arthropods such as insects, crustaceans, spiders, and myriapods, as well as mollusks. Preferred animals are mammals, and preferred mammals are humans.
[0021] The culture supernatant of a cell is the supernatant of a culture medium in which cells are cultured. The culture medium may be a medium that does not contain glucose, but preferably the culture medium is a medium that contains glucose. Glucose has the molecular formula CH 12Glucose is a sugar having an O6 atom. Examples of glucose include D-glucose and L-glucose. The glucose content in a glucose-containing medium, as the content at the time of completing the cell culture in the glucose-containing medium, is preferably 0.5 to 20 g / L relative to the medium, more preferably 0.5 to 9.0 g / L relative to the medium, even more preferably 1.0 to 9.0 g / L relative to the medium, even more preferably 3.0 to 8.0 g / L relative to the medium, even more preferably 4.0 to 6.0 g / L relative to the medium, and even more preferably 4.5 to 6.0 g / L relative to the medium. When the culture medium does not contain glucose or contains glucose, the glucose content in the medium is, as the content at the time of completing the cell culture in the medium, preferably 0 to 20 g / L, more preferably 0 to 10 g / L, even more preferably 0 to 9.0 g / L, even more preferably 0 to 8.0 g / L, even more preferably 0 to 6.0 g / L, and even more preferably 0 to 4.5 g / L. Examples of the medium containing glucose include basal medium. The cell culture supernatant is the supernatant of a culture medium in which cells are cultured, and when the culture medium is a medium containing glucose, the cells are cultured in the glucose-containing medium for preferably 1 hour or more, more preferably 5 hours or more, more preferably 10 hours or more, more preferably 15 hours or more, more preferably 20 hours or more, more preferably 25 hours or more, more preferably 30 hours or more, more preferably 35 hours or more, more preferably 40 hours or more, and most preferably 45 hours or more. Also, the cells are cultured in the glucose-containing medium for preferably 100 hours or less, more preferably 90 hours or less, more preferably 80 hours or less, more preferably 70 hours or less, more preferably 60 hours or less, and more preferably 50 hours or less.The cell culture supernatant is the supernatant of a culture medium in which cells are cultured. When the culture medium is a medium containing glucose, the cell culture is started at a concentration of preferably 1,000 to 10,000 cells / cm in the glucose-containing medium. 2 More preferably, the cells are seeded at a cell density of 3,000 to 10,000 cells / cm. 2 More preferably, the cells are seeded at a cell density of 5,000 to 7,500 cells / cm. 2 The cells are seeded at a cell density of 1000×.
[0022] The cells in the cell culture supernatant are preferably washed before being cultured in a glucose-containing medium. Here, washing is performed, for example, with a buffer such as phosphate-buffered saline (PBS). Here, the number of washings is, for example, 1 to 5 times, preferably 1 to 3 times, and more preferably 2 times.
[0023] The cells in the cell culture supernatant are, for example, those cultured in a medium containing a recombinant protein. The cells in the cell culture supernatant are preferably those cultured in a medium containing glucose, and are cultured in a medium containing a recombinant protein before being cultured in a medium containing glucose. The cells in the cell culture supernatant are preferably those cultured in a medium containing glucose, and are washed before being cultured in a medium containing glucose, and are cultured in a medium containing a recombinant protein before the washing. Examples of recombinant proteins include FGF2, EGF, insulin, and the like. The medium containing recombinant proteins may be, for example, a serum-free medium. Examples of the medium containing recombinant proteins include a medium for stem cells, such as a medium for adipose-derived stem cells and a medium for mesenchymal stem cells. The medium containing recombinant proteins may include an additive, and examples of the additive include an additive for mesenchymal stem cells, and examples of the additive for mesenchymal stem cells include a basal culture medium additive for animal mesenchymal stem cells, such as mammals, such as humans. Moreover, the additive herein is preferably an animal-free additive. Animal-free means that it does not contain components derived from animal factors, and the "animal-free" below has the same meaning. The cells in the cell culture supernatant have been cultured in a medium containing a recombinant protein, preferably for 0 to 336 hours, more preferably for 72 to 168 hours, and even more preferably for 96 to 120 hours. Here, the culture time is, for example, the time from thawing the cells when culturing frozen cells.
[0024] The cells in the cell culture supernatant are, for example, those cultured in a serum-free medium. The cells in the cell culture supernatant are preferably those cultured in a medium containing glucose, and those cultured in a serum-free medium before being cultured in the medium containing glucose. The cells in the cell culture supernatant are preferably those cultured in a medium containing glucose, and those washed before being cultured in the medium containing glucose, and those cultured in a serum-free medium before the washing. The serum-free medium may contain, for example, a recombinant protein. Examples of the medium in the serum-free medium include a medium for stem cells, such as a medium for adipose-derived stem cells and a medium for mesenchymal stem cells. The serum-free medium may contain an additive, and examples of the additive include an additive for mesenchymal stem cells, and examples of the additive for mesenchymal stem cells include a basal culture medium additive for mesenchymal stem cells of animals, such as mammals, including humans. The additive is preferably an animal-free additive. The cells in the cell culture supernatant have been cultured in a serum-free medium for preferably 0 to 336 hours, more preferably 72 to 168 hours, and even more preferably 96 to 120 hours. Here, the culture time is, for example, the time from thawing the cells when culturing frozen cells.
[0025] The cells in the cell culture supernatant are, for example, those cultured in a stem cell medium such as a medium for adipose-derived stem cells or a medium for mesenchymal stem cells. The cells in the cell culture supernatant are preferably those cultured in a medium containing glucose, and are cultured in a stem cell medium such as a medium for adipose-derived stem cells or a medium for mesenchymal stem cells before being cultured in a medium containing glucose. The cells in the cell culture supernatant are preferably those cultured in a medium containing glucose, and are washed before being cultured in a medium containing glucose, and are cultured in a stem cell medium such as a medium for adipose-derived stem cells or a medium for mesenchymal stem cells before being washed. Here, the stem cell medium such as a medium for adipose-derived stem cells or a medium for mesenchymal stem cells may be, for example, a serum-free medium, may contain a recombinant protein, or may be a serum-free medium containing a recombinant protein. Examples of the medium for adipose-derived stem cells include, for example, ADSC-4 medium and the like. Examples of mesenchymal stem cell media include CiMS medium, StemFit (registered trademark) for Mesenchymal Stem Cell, R:STEM, and the like. Stem cell media such as adipose-derived stem cell medium and mesenchymal stem cell medium may contain additives. Here, examples of additives include additives for mesenchymal stem cells, and examples of additives for mesenchymal stem cells include additives for basal culture medium for mesenchymal stem cells of animals such as mammals including humans. Here, additives are preferably animal-free additives. The cells in the cell culture supernatant are preferably cultured in a stem cell medium such as adipose-derived stem cell medium and mesenchymal stem cell medium for 0 to 336 hours, more preferably 72 to 168 hours, and even more preferably 96 to 120 hours. Here, the culture time is, for example, the time after thawing the cells in the case of culturing frozen cells.
[0026] The cell culture supernatant is the supernatant of a culture solution in which cells are cultured, and preferably, the cell culture supernatant is obtained by filtering the culture solution through a filter. The thing obtained by filtering the culture solution through a filter is not limited to the thing obtained immediately after filtering the culture solution through a filter, but may include the thing obtained by processing the thing obtained immediately after filtering the culture solution through a filter. The filtration grain size of the filter is preferably 0.1 μm to 1.0 μm, more preferably 0.1 μm to 0.6 μm, and even more preferably 0.1 μm to 0.3 μm. The cell culture supernatant may be a concentrated solution of exosomes.
[0027] The content of cell culture supernatant in the composition for freeze-drying of the present invention is preferably 0.1 to 94.8% by mass, more preferably 50 to 94.8% by mass, and even more preferably 90 to 94.8% by mass, based on the composition for freeze-drying.
[0028] The composition for freeze-drying of the present invention may contain other substances such as excipients, additives, buffers, salts for adjusting isotonicity, antioxidants, preservatives, and drug stabilizers in addition to the cell culture supernatant, trehalose, and hyaluronate. Examples of excipients include water, purified water, alcohol, glycerin, lactose, starch, dextrin, sucrose, precipitated silica, honey, rice starch, and tragacanth. The content of other substances other than the cell culture supernatant, trehalose, and hyaluronate contained in the composition for freeze-drying of the present invention is, for example, 0.1 to 50% by mass relative to the composition for freeze-drying of the present invention.
[0029] The pH of the composition for lyophilization of the present invention is preferably 5-11, more preferably 6-10, and even more preferably 7-9.
[0030] A freeze-dried product can be obtained by freeze-drying the composition for freeze-drying of the present invention. The freeze-drying is carried out, for example, using an apparatus such as FDL1000 (Tokyo Rikakikai Co., Ltd.) at a temperature of, for example, -40 to +40°C. In the freeze-drying, for example, the composition for freeze-drying of the present invention is exposed in a frozen state to a high vacuum, whereby water is removed by sublimation from a solid to a gas. The freeze-drying is carried out, for example, in a sterile environment. The freeze-dried product of the present invention can be used, for example, as a pharmaceutical composition, a cosmetic composition, an active ingredient thereof, or a food such as a health food. When a pharmaceutical composition, cosmetic composition, or food contains the freeze-dried product of the present invention, the content of the freeze-dried product of the present invention is, for example, 0.1% or more, 0.5% or more, 1% or more, 2% or more, 3% or more, 4% or more, 5% or more, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, or 90% or more relative to the pharmaceutical composition, cosmetic composition, or food. The content of the freeze-dried product of the present invention is, for example, 99.9% or less, 99% or less, 95% or less, 90% or less, 80% or less, 70% or less, 60% or less, 50% or less, 40% or less, 30% or less, 20% or less, or 10% or less relative to the pharmaceutical composition, cosmetic composition, or food.
[0031] In addition, in [Item 1] to [Item 22] of this specification, when it is stated that "A is B," such as "the cell is a stem cell" ([Item 2]), "A is B" does not only imply that "A" is only "B," but also that "A" includes "B" and also includes other "things included in A" (excluding cases where B is a numerical range). However, since "A is B" includes that "A" is only "B," amending the statement "A is only B" based on the statement "A is B" remains within the scope of the matters described in this specification. EXAMPLES
[0032] Test example 1: Human umbilical cord tissue-derived stem cells were cultured and expanded in ADSC-4 medium (Kohjin Bio Co., Ltd.) containing recombinant proteins. ADSC-4 medium containing recombinant proteins is a serum-free medium for adipose-derived stem cells. When the cells reached subconfluency, they were detached using TrypLE (trademark) Select and subcultured. After subculture, the cells were cultured at 3000 cells / cm. 2 The cells were reseeded at a cell density of 0.01 to 0.01 g / L. TrypLE (trademark) Select is a cell dissociation enzyme. In the growth culture after the third subculture operation, when the cells reached confluence, the existing ADSC-4 medium was removed, and the cells were washed twice with PBS to remove the recombinant protein contained in the medium. Thereafter, the cells were transferred to a medium containing glucose at a concentration of 4.5 g / L or more, obtained by adding glucose to the basal medium, and growth cultured for 48 hours. Considering the amount of glucose consumed by the cells during growth culture, it is estimated that the concentration of glucose contained in the medium at the end of the 48-hour growth culture was 0 to 4.5 g / L. After the growth culture, the cell supernatant was collected and filtered through a filter with a filtration grain size of 0.22 μm to obtain a culture supernatant.
[0033] Test example 2: Human umbilical cord tissue-derived stem cells were cultured and expanded in CiMS medium (Nipro) containing recombinant proteins, to which AF supplement (Nipro) was added. AF supplement is an animal-free additive to the basal culture medium for human mesenchymal stem cells. CiMS medium containing recombinant proteins is a medium for human mesenchymal stem cells. When the cells reached confluence, the existing CiMS medium was removed, and the cells were washed twice with PBS to remove the recombinant proteins contained in the medium. The cells were then transferred to a medium containing glucose at a concentration of 4.5 g / L or more, which was obtained by adding glucose to the basal medium, and cultured for 48 hours. Considering the amount of glucose consumed by the cells during the growth culture, it is estimated that the concentration of glucose contained in the medium at the end of the 48-hour growth culture was 0 to 4.5 g / L. After the growth culture, the cell supernatant was collected and filtered through a filter with a filtration grain size of 0.22 μm to obtain a culture supernatant.
[0034] Test example 3: A concentrated solution of exosomes was obtained from the culture supernatant obtained in Test Example 1.
[0035] Comparative Example 1: Only the culture supernatant obtained in Test Example 1 was freeze-dried. The freeze-drying machine used was FDL1000 (Tokyo Rikakikai Co., Ltd.). The appearance of the freeze-dried product obtained by freeze-drying the culture supernatant is shown in FIG. As shown in Figure 1, during freeze-drying of the culture supernatant, the frozen solids rose up and left a mark in the center of the vial. In addition, the resulting freeze-dried product had a high degree of variation in appearance, leading to complaints.
[0036] Comparative Example 2: Trehalose (dihydrate) was added to the culture supernatant obtained in Test Example 1 to obtain a composition for freeze-drying containing 5% by mass of trehalose (dihydrate), and the obtained composition for freeze-drying was freeze-dried. The freeze-drying machine used was FDL1000 (Tokyo Rikakikai Co., Ltd.). The appearance of the freeze-dried product obtained by freeze-drying the composition for freeze-drying is shown in the leftmost photograph of FIG. 4. As shown in the leftmost photograph in FIG. 4, the generation of air bubbles was observed in the obtained freeze-dried product.
[0037] Comparative Example 3: Sodium hyaluronate (molecular weight: 600,000; origin: microorganism) was added to the culture supernatant obtained in Test Example 1 to obtain a composition for freeze-drying containing 0.1% by mass or 0.2% by mass of sodium hyaluronate (molecular weight: 600,000; origin: microorganism), and the obtained composition for freeze-drying was freeze-dried. In the freeze-drying, FDL1000 (Tokyo Rika Kikai Co., Ltd.) was used as the machine. The appearance of the freeze-dried product obtained by freeze-drying the composition for freeze-drying is shown in Figures 2 and 3. Figure 2 shows the results when the content of sodium hyaluronate (molecular weight: 600,000; origin: microorganism) is 0.1% by mass, and Figure 3 shows the results when the content of sodium hyaluronate (molecular weight: 600,000; origin: microorganism) is 0.2% by mass. As shown in Figures 2 and 3, the freeze-dried product obtained had a sponge-like structure with many holes due to the generation of air bubbles, and had poor stability during molding, which led to variations in appearance between vials and led to complaints.
[0038] Comparative Example 4: Sodium hyaluronate (molecular weight: 600,000; origin: microorganism) was added to the culture supernatant obtained in Test Example 1 to obtain a composition for freeze-drying containing more than 0.5% by mass of sodium hyaluronate (molecular weight: 600,000; origin: microorganism). The obtained composition for freeze-drying was attempted to be freeze-dried using an FDL1000 machine (Tokyo Rikakikai Co., Ltd.), but the obtained composition for freeze-drying had high viscosity and was difficult to handle as a product characteristic.
[0039] Comparative Example 5: Trehalose (dihydrate) and, if necessary, mannitol were added to the culture supernatant obtained in Test Example 1 to obtain a composition for freeze-drying containing 5% by mass of trehalose (dihydrate) and 0 to 30 mg / ml of mannitol, and the obtained composition for freeze-drying was freeze-dried. The freeze-drying machine used was FDL1000 (Tokyo Rika Kikai Co., Ltd.). The appearance of the freeze-dried product obtained by freeze-drying the composition for freeze-drying is shown in FIG. 4. FIG. 4 shows the results when the content of trehalose (dihydrate) is 5% by mass and the content of mannitol is 0 mg / ml, 10 mg / ml, 20 mg / ml, and 30 mg / ml, from the left. The content of mannitol is the mass (mg) of mannitol relative to the total amount (ml) of the composition for freeze-drying. As shown in Figure 4, the generation of large air bubbles was observed in the freeze-dried product obtained by adding trehalose (dihydrate). The addition of another excipient, mannitol, did not improve the appearance, and instead caused swelling.
[0040] Comparative Example 6: Trehalose (dihydrate) and, if necessary, mannitol were added to the culture supernatant obtained in Test Example 1 to obtain a composition for freeze-drying containing 10% by mass of trehalose (dihydrate) and 0 to 30 mg / ml of mannitol, and the obtained composition for freeze-drying was freeze-dried. The freeze-drying machine used was FDL1000 (Tokyo Rika Kikai Co., Ltd.). The appearance of the freeze-dried product obtained by freeze-drying the composition for freeze-drying is shown in FIG. 5. FIG. 5 shows the results when the content of trehalose (dihydrate) was 10% by mass and the content of mannitol was 0 mg / ml, 10 mg / ml, 20 mg / ml, and 30 mg / ml, from the left. The content of mannitol is the mass (mg) of mannitol relative to the total amount (ml) of the composition for freeze-drying. As shown in Figure 5, the appearance of the freeze-dried product improved when the amount of trehalose (dihydrate) was increased from 5% by mass to 10% by mass, but the product was wavy and had spaces due to shrinkage at the bottom of the bottle, and thus did not achieve perfect molding.
[0041] Example 1: Trehalose (dihydrate) and sodium hyaluronate (molecular weight: 600,000; origin: microorganism) were added to the culture supernatant obtained in Test Example 1 to obtain a composition for freeze-drying containing 5% by mass of trehalose (dihydrate) and 0.2% by mass of sodium hyaluronate (molecular weight: 600,000; origin: microorganism), and the obtained composition for freeze-drying was freeze-dried. The freeze-drying machine used was FDL1000 (Tokyo Rika Kikai Co., Ltd.). The appearance of the freeze-dried product obtained by freeze-drying the composition for freeze-drying is shown in FIG. 6. The pH of the obtained composition for freeze-drying was 8.5. As shown in Figure 6, the freeze-dried product obtained had no air bubbles, no lifting of the frozen solids, and no variation between vials, and was not worthy of the claims. From the above, cells such as stem cells derived from human umbilical cord tissues can be cultured 2 to 10 times, with cell detachment and other procedures, to produce cells at a density of 1,000 to 10,000 cells / cm. 2The cells were then reseeded at a cell density of 0.5 to 20 g / L and grown in a medium containing the recombinant protein. The cells were then washed to remove the recombinant protein from the medium, and grown in a medium containing glucose at a concentration of 0.5 to 20 g / L to terminate the growth culture. The culture medium was filtered through a filter with a filtration grain size of 0.1 μm to 1.0 μm. The culture supernatant was freeze-dried, and bubbles were observed even when trehalose (dihydrate) was added. Even if trehalose (dihydrate) is added, it may have a sponge-like structure after freeze-drying and has poor stability during molding. However, it was completely unexpected that a composition containing 1-10% by mass of trehalose (dihydrate), 0.01-0.5% by mass of hyaluronate such as sodium hyaluronate (molecular weight: 600,000; origin: microorganism), and the above culture supernatant does not generate bubbles, does not lift the frozen solid, and does not vary between vials, and realizes an excellent product shape, making it excellent as a composition for freeze-drying. It was also revealed that a composition containing 5-10% by mass of trehalose (dihydrate), 0.1-0.3% by mass of hyaluronate such as sodium hyaluronate (molecular weight: 600,000; origin: microorganism), and the above culture supernatant is particularly excellent as a composition for freeze-drying. These findings are extremely unexpected, since the use of mannitol, another excipient, together with trehalose (dihydrate) did not improve the appearance, and instead swelling was observed.
[0042] Example 2: When the culture supernatant obtained in Test Example 2 was subjected to the same experiments as in Comparative Examples 1 to 6 and Example 1, the same results were obtained.
[0043] Example 3: When the exosome concentrate obtained in Test Example 3 was subjected to the same experiments as in Comparative Examples 1 to 6 and Example 1, similar results were obtained.
Claims
1. A composition for freeze-drying comprising a cell culture supernatant, trehalose, and a hyaluronate.
2. The composition for freeze-drying according to claim 1 , wherein the cells are stem cells.
3. The composition for freeze-drying according to claim 2 , wherein the stem cells are umbilical cord tissue-derived stem cells.
4. 2. The composition for freeze-drying according to claim 1, wherein the cell culture supernatant is a supernatant of a culture medium in which cells are cultured, and the culture medium is a medium containing glucose.
5. The composition for freeze-drying according to claim 4, wherein the glucose content in the glucose-containing medium is 0.5 to 20 g / L relative to the medium when the culture of the cells in the glucose-containing medium is terminated.
6. The composition for freeze-drying according to claim 4 , wherein the medium in the medium containing glucose is a basal medium.
7. The composition for lyophilization according to claim 4, wherein the cells are washed before being cultured in a medium containing glucose.
8. The composition for lyophilization according to claim 1 , wherein the cells are cultured in a medium containing the recombinant protein.
9. The composition for freeze-drying according to claim 1 , wherein the cells are cultured in a serum-free medium.
10. The composition for freeze-drying according to claim 1 , wherein the cells are cultured in a medium for adipose-derived stem cells.
11. The composition for freeze-drying according to claim 1 , wherein the cells are cultured in a medium for mesenchymal stem cells.
12. 2. The composition for freeze-drying according to claim 1, wherein the cell culture supernatant is a supernatant of a culture solution in which cells are cultured, and the cell culture supernatant is obtained by filtering the culture solution through a filter.
13. The composition for freeze-drying according to claim 12, wherein the filter has a filtration grain size of 0.1 μm to 1.0 μm.
14. The composition for freeze-drying according to claim 1 , wherein the cell culture supernatant is a concentrated solution of exosomes.
15. 2. The composition for freeze-drying according to claim 1, wherein the content of trehalose in the composition for freeze-drying is 1 to 10% by mass, and the content of the hyaluronate in the composition for freeze-drying is 0.01 to 0.5% by mass.
16. The composition for freeze-drying according to claim 15, wherein the content of trehalose in the composition for freeze-drying is 5 to 10% by mass, and the content of the hyaluronate in the composition for freeze-drying is 0.1 to 0.3% by mass.
17. 2. The composition for lyophilization according to claim 1, wherein the hyaluronate is sodium hyaluronate.
18. A lyophilized product obtained by freeze-drying the composition for freeze-drying according to any one of claims 1 to 17.
19. 20. A pharmaceutical composition, a cosmetic composition, or a food product comprising the lyophilisate according to claim 18.
Citation Information
Patent Citations
Lyophilized therapeutic peptibody formulations
JP2022166219A
Compositions and methods for treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces - Patent Application 20070122999
JP2022191232A
